NCT02308098View on ClinicalTrials.gov

To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product

PHASE3CompletedINTERVENTIONAL
Enrollment

72

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2015

Conditions
Asthma
Interventions
DRUG

Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh

DRUG

Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh

DRUG

Symbicort Turbuhaler 320/9 ug/inhalation 4 inh

DRUG

Symbicort Turbuhaler 320/9 ug/inhalation 1inh

DRUG

Placebo Symbicort Turbuhaler 320/9 ug/inhalation 4 inh

DRUG

Placebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 4 inh

DRUG

Placebo Budesonide/Formoterol Easyhaler 320/9 ug/inhalation 1 inh

DRUG

Placebo Symbicort Turbuhaler 320/9 ug/inhalation 1 inh

Trial Locations (1)

Unknown

Specialized Hospital for Active Treatment for Pneumophthisiatric Diseases Dr Dimitar Gramatikov-Ruse EOOD, Rousse

All Listed Sponsors
lead

Orion Corporation, Orion Pharma

INDUSTRY

NCT02308098 - To Confirm Equivalent Bronchodilator Efficacy of the Test Product Compared to the Reference Product | Biotech Hunter | Biotech Hunter